Kaleido Biosciences, Inc.KLDOOTCMARKET
Loading
Trailing Twelve Months (TTM) Metrics
Per Share (TTM)
Revenue/Share$0.03
Net Income/Share$-2.16
Operating CF/Share$-1.84
Free CF/Share$-1.87
Cash/Share$0.92
Book Value/Share$0.25
Tangible Book/Share$0.31
Equity/Share$0.25
Interest Debt/Share$0.59
CapEx/Share$0.03
Dividend/Share$0.00
Valuation
Market Cap$4.26K
Enterprise Value-$16.78M
P/E Ratio-0.00P/S Ratio0.00P/OCF Ratio-0.00
P/FCF Ratio-0.00
P/B Ratio0.00P/TB Ratio0.00
EV/Sales-15.20EV/EBITDA0.20
Graham Valuation
Graham Number--
Graham Net-Net$-0.03
Profitability
Earnings Yield-2156904.33%FCF Yield-1835358.99%ROE-580.57%ROIC-239.53%Return on Tangible Assets-172.05%Dividend
Dividend Yield0.00%Payout Ratio0.00%Capital Allocation
CapEx/OCF-1.46%
CapEx/Revenue102.26%
CapEx/Depreciation0.48
SBC/Revenue936.78%
SG&A/Revenue1899.28%
R&D/Revenue6141.58%
Liquidity & Solvency
Debt/Equity2.05Debt/Assets0.43Debt/Market Cap5,090.10
Net Debt/EBITDA0.20
Current Ratio1.43Interest Coverage-30.89xIncome Quality0.85Efficiency
Days Sales Outstanding0 days
Days Payables Outstanding878 days
Days Inventory0 days
Receivables Turnover0.00x
Payables Turnover0.42x
Inventory Turnover0.00x
Capital Structure
Tangible Assets$12.95M
Working Capital$12.63M
Invested Capital$15.95M
Intangibles/Assets-4.67%